The board of directors of Biotage AB (STO:BIOTA) (publ) has resolved to start a share buy-back program in accordance with the Annual General Meeting’s resolution to authorize the board to decide on the acquisition and sale of the company’s own shares. At the Annual General Meeting held on 26 April 2012, the board was authorized […]
Ghent, Belgium – Trinean NV today announced the appointment of Philippe Stas as it’s new CEO, succeeding Dr. Marc Zabeau, who remains a member of the board of directors. Simultaneously, Trinean announced that the company has secured 2.7 million euro of growth financing provided by its existing investors. “We are delighted to have Philippe on […]
Ghent, Belgium – Trinean NV today announced the appointment of Philippe Stas as it’s new CEO, succeeding Dr. Marc Zabeau, who remains a member of the board of directors. Simultaneously, Trinean announced that the company has secured 2.7 million euro of growth financing provided by its existing investors. “We are delighted to have Philippe on […]
Jena, — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) expects another sales and earnings increase for the current financial year 2011/2012. The Company forecasts consolidated sales of approximately EUR 91.0 m to EUR 93.0 m. Analytik Jena wants to achieve more than EUR 6.0 m in operating profit (EBIT) at the end of the […]
At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved all board proposals by a large majority. Thus, the Annual Shareholders’ Meeting passed the resolution to pay dividends of 0.82 euro per preference share (previous year: 0.62 euro) and 0.80 euro per ordinary share (previous year: 0.60 euro). Accordingly, the total amount of dividends to […]
Plexpress has announced follow-on funding of up to $2.3M to commercialise its novel TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-content gene expression analysis. The investment has been secured to commercialise the technology internationally, build up the ADMET screening service and develop TRAC specifically within the oncology sector. Existing investors – […]
Männedorf, Switzerland, – The Annual General Meeting of the Tecan Group has today endorsed all motions proposed by the Board of Directors. The shareholders approved the Annual Report, the financial statements and the consolidated financial statements, and granted discharge to the Board of Directors and the Management Board. They also approved a significantly higher dividend […]
SAN DIEGO,– Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported that more than 12,700 total tests, including in excess of 4,900 MaterniT21 PLUS laboratory-developed tests (LDT) offered by Sequenom Center for Molecular Medicine (Sequenom CMM), were accessioned during the first quarter of 2012. This equates to an annualized […]
SOUTH EASTON, Mass.— Pressure BioSciences, Inc.(“PBI” or the “Company”) today announced that it has entered into a definitive agreement with Ironridge BioPharma Co. (“Ironridge”) to purchase $500,000.00 in shares of Series E Convertible Preferred Stock (the “Preferred Stock”) of the Company. Each share of the 500 shares of Preferred Stock to be sold to Ironridge […]
South Easton, MA,– Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that its common stock will begin trading on the OTCQB tier of the OTC Marketplace (“OTCQB”) effective today, Thursday, April 5, 2012. The OTCQB is a market tier for OTCtraded companies that are registered and current in their reporting with the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
